Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 344 entries
View as:

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06102772 Org: User:
Start: 11/10/23 End: 10/10/26 Due: 10/10/27

Immunotherapy Versus Chemotherapy as Adjuvant Therapy for Colon Cancer With MSI-H or POLE/ POLD1 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT04969029 Org: User:
Start: 06/01/21 End: 12/31/24 Due: 12/31/25

Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01796717 Org: User:
Start: 03/31/12 End: 12/31/16 Due: 12/31/17

Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06512467 Org: User:
Start: 07/30/24 End: 12/31/26 Due: 12/31/27

Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04126811 Org: User:
Start: 06/01/19 End: 12/31/20 Due: 12/31/21

Second-line Immunotherapy for ES-SCLC

Phase: N/A Priority: Normal
NCT ID: NCT06853678 Org: User:
Start: 02/28/25 End: 03/01/27 Due: 03/01/28

To Evaluate the Efficacy and Safety of Anrotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06352008 Org: User:
Start: 07/01/24 End: 06/01/26 Due: 06/01/27

Granisetron Transdermal Patch System for Prevention of CINV by CapeOX

Phase: N/A Priority: Normal
NCT ID: NCT05325190 Org: User:
Start: 10/10/21 End: 06/01/23 Due: 06/01/24

A Multicenter, Open and Observational Real World Study on the Prognosis and Treatment in Young Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04970264 Org: User:
Start: 04/01/20 End: 03/31/25 Due: 03/31/26

Single-center, Prospective Study on the Identification and Delineation of Brain and Lung Tumors and At-Risk Organs, and Functional Testing of Surrounding Tissues Based on Dual-Energy CT

Phase: N/A Priority: Normal
NCT ID: NCT06301100 Org: User:
Start: 04/28/23 End: 12/31/24 Due: 12/31/25

A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05871918 Org: User:
Start: 10/08/22 End: 12/31/23 Due: 12/31/24

Retrospective Analysis of Effectiveness and Safety Profile of Anastrozole and Letrozole in HR+ Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02812277 Org: User:
Start: 07/31/16 End: 11/30/17 Due: 11/30/18

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01430013 Org: User:
Start: 06/30/11 End: 12/31/15 Due: 12/31/16

Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.

Phase: N/A Priority: Normal
NCT ID: NCT05723978 Org: User:
Start: 01/01/11 End: 12/01/22 Due: 12/01/23

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04193098 Org: User:
Start: 06/01/19 End: 06/01/21 Due: 06/01/22

The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01634984 Org: User:
Start: 01/31/12 End: 12/31/16 Due: 12/31/17

Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection

Phase: N/A Priority: Normal
NCT ID: NCT03779035 Org: User:
Start: 12/15/18 End: 12/31/23 Due: 12/31/24

Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04063462 Org: User:
Start: 10/01/19 End: 10/01/21 Due: 10/01/22

Clinical Application of Breast Blood-oxygen Functional Imaging Technology

Phase: N/A Priority: Normal
NCT ID: NCT01678170 Org: User:
Start: 09/30/12 End: 12/31/16 Due: 12/31/17

QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06917092 Org: User:
Start: 05/01/25 End: 04/30/30 Due: 04/30/31

A Multicenter Randomized Controlled Clinical Trial of the Impact of Minimally Invasive Abdominal Surgery Esophageal Pressure Monitoring Guided Individualized PEEP on Postoperative Pulmonary Complications in Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT06996288 Org: User:
Start: 05/20/25 End: 12/31/27 Due: 12/31/28

The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06208436 Org: User:
Start: 10/07/23 End: 02/28/24 Due: 02/28/25

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02780778 Org: User:
Start: 05/31/16 End: 12/31/17 Due: 12/31/18

Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05627414 Org: User:
Start: 01/01/23 End: 01/01/25 Due: 01/01/26

A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04733417 Org: User:
Start: 05/26/21 End: 09/30/23 Due: 09/30/24